Work

A phase I study of bevacizumab (B) with fluorouracil (F) and hydroxyurea (H) with concomitant radiotherapy (X) (B-FHX) for poor prognosis head and neck cancer (HNC)

Year: 2006

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2006.24.18_suppl.5530

Authors: T. Y. Seiwert, D. J. Haraf, E. E. Cohen, K. Stenson, A. M. Mauer, A. Dekker, C. Bajda, R. R. Weichselbaum, H. X. Chen, E. E. Vokes

Institutions: University of Chicago, National Cancer Institute

Language: English

Topic: Head and Neck Cancer Studies

Subfield: Otorhinolaryngology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2242447589

Cites:

Cited by: 24

Related to: 10